Sands Capital Life Sciences Pulse Fund II, L.P. - Insider Trading & Ownership

Entity
Company
Location
C/O Sands Capital Ventures, Llc, 1000 Wilson Boulevard, Suite 3000, Arlington, VA
Summary
The estimated value of insider holdings of Sands Capital Life Sciences Pulse Fund II, L.P. is at least $15M dollars as of October 25, 2024. Sands Capital Life Sciences Pulse Fund II, L.P. is the 10%+ Owner of Inhibikase Therapeutics, Inc. and owns shares of Inhibikase Therapeutics, Inc. (IKT) stock worth about $15M.
All Insider Reports
All Insider Reports

Ownership of Sands Capital Life Sciences Pulse Fund II, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IKT Inhibikase Therapeutics, Inc. 10%+ Owner $15M Oct 21, 2024

There are no insider transactions reported by Sands Capital Life Sciences Pulse Fund II, L.P.